Monal Mehta

Board Member at Endeavor Biomedicines

Monal Mehta, Ph.D., is a Therapeutics Analyst on the Avidity Partners private investment team. Previously, she was a Director at Pfizer Oncology where she was a key member of the Business Development team responsible for several pre-clinical and clinical-stage licensing and acquisition opportunities. Monal also served as Alliance Manager for Pfizer Oncology. Prior to Pfizer, she was at Navigant Consulting in the Life Sciences practice. Monal holds a Ph.D. in Cancer Biology and Pharmacology from the University of Medicine and Dentistry of New Jersey and was an NSF fellow.

Timeline

  • Board Member

    Current role